American Journal of Public Health, Vol 90, Issue 7 1112-1116, Copyright © 2000 by American Public Health Association

JOURNAL ARTICLE

Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997

C Des Jarlais, T Perlis, SR Friedman, T Chapman, J Kwok, R Rockwell, D Paone, J Milliken and E Monterroso
Beth Israel Medical Center, Chemical Dependency Institute, New York, NY 10003, USA. dcdesjarla@aol.com

OBJECTIVES: This study assessed trends in HIV risk behaviors among injection drug users in New York City from 1990 to 1997. METHODS: Injection drug users were recruited continuously from a large drug detoxification treatment program (N = 2588) and a research storefront located in a high-drug-use area (N = 2701). Informed consent was obtained, and a trained interviewer administered a structured interview covering sociodemographics, drug use history, HIV risk behavior, and participation in syringe exchange. RESULTS: Trends were assessed for 5 risk behaviors in the 6-month period before the interview. The 3 injection risk behaviors declined significantly over time at each site (all P < .01). When data were pooled across sites, all 5 risk behaviors declined significantly over time (all P < .01). Participation in syringe exchange programs and in HIV counseling and testing increased greatly from 1990 to 1997. CONCLUSIONS: The continuing risk reduction among injection drug users indicates a "declining phase" in the large HIV epidemic in New York City. HIV prevention programs appear to be making an important contribution to the declining phase.

This article has been cited by other articles:

				D. C. Des Jarlais, K. Arasteh, H. Hagan, C. McKnight, D. C. Perlman, and S. R. Friedman Persistence and Change in Disparities in HIV Infection Among Injection Drug Users in New York City After Large-Scale Syringe Exchange Programs Am J Public Health, October 1, 2009; 99(S2): S445 - S451. [Abstract] [Full Text] [PDF]

				D. C. D. Jarlais and S. Semaan HIV Prevention for Injecting Drug Users: The First 25 Years and Counting Psychosom Med, June 1, 2008; 70(5): 606 - 611. [Abstract] [Full Text] [PDF]

				D. C. Des Jarlais, T. Perlis, K. Arasteh, L. V. Torian, S. Beatrice, J. Milliken, D. Mildvan, S. Yancovitz, and S. R. Friedman HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services Am J Public Health, August 1, 2005; 95(8): 1439 - 1444. [Abstract] [Full Text] [PDF]

				N. Galai, M. Safaeian, D. Vlahov, A. Bolotin, and D. D. Celentano Longitudinal Patterns of Drug Injection Behavior in the ALIVE Study Cohort,1988-2000: Description and Determinants Am. J. Epidemiol., October 1, 2003; 158(7): 695 - 704. [Abstract] [Full Text] [PDF]

				Trends in Injection Drug Use Among Persons Entering Addiction Treatment--New Jersey, 1992-1999 JAMA, June 6, 2001; 285(21): 2706 - 2707. [Full Text] [PDF]